It’s like a small forest,” says architect Rebecca Benichou, referring to a charmed private garden in the heart of Paris.

South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerate its transformation into an original drug developer.